Quantitative proteomics profiling of primary lung adenocarcinoma tumors reveals functional perturbations in tumor metabolism.

In this study, we have analyzed human primary lung adenocarcinoma tumors using global mass spectrometry to elucidate the biological mechanisms behind relapse post surgery. In total, we identified over 3000 proteins with high confidence. Supervised multivariate analysis was used to select 132 proteins separating the prognostic groups. Based on in-depth bioinformatics analysis, we hypothesized that the tumors with poor prognosis had a higher glycolytic activity and HIF activation. By measuring the bioenergetic cellular index of the tumors, we could detect a higher dependency of glycolysis among the tumors with poor prognosis. Further, we could also detect an up-regulation of HIF1α mRNA expression in tumors with early relapse. Finally, we selected three proteins that were upregulated in the poor prognosis group (cathepsin D, ENO1, and VDAC1) to confirm that the proteins indeed originated from the tumor and not from a stromal or inflammatory component. Overall, these findings show how in-depth analysis of clinical material can lead to an increased understanding of the molecular mechanisms behind tumor progression.

[1]  A. Harris,et al.  How cancer metabolism is tuned for proliferation and vulnerable to disruption , 2012, Nature.

[2]  Yoo Jin Jung,et al.  The transcriptional landscape and mutational profile of lung adenocarcinoma , 2012, Genome research.

[3]  M. Okada,et al.  Cathepsin D as a potential prognostic marker for lung adenocarcinoma. , 2012, Pathology, research and practice.

[4]  Li Ding,et al.  Genomic Landscape of Non-Small Cell Lung Cancer in Smokers and Never-Smokers , 2012, Cell.

[5]  K. Cibulskis,et al.  Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer , 2012, Nature Genetics.

[6]  Angela N. Brooks,et al.  Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing , 2012, Cell.

[7]  Nadav S. Bar,et al.  Landscape of transcription in human cells , 2012, Nature.

[8]  Chih-Chiang Tsou,et al.  Label-free Quantitative Proteomics and N-Glycoproteomics Analysis of KRAS-activated Human Bronchial Epithelial Cells* , 2012, Molecular & Cellular Proteomics.

[9]  P. Massion,et al.  In-depth Proteomic Analysis of Nonsmall Cell Lung Cancer to Discover Molecular Targets and Candidate Biomarkers* , 2012, Molecular & Cellular Proteomics.

[10]  V. Shoshan-Barmatz,et al.  Expression of a truncated active form of VDAC1 in lung cancer associates with hypoxic cell survival and correlates with progression to chemotherapy resistance. , 2012, Cancer research.

[11]  Vito Pistoia,et al.  Fasting Cycles Retard Growth of Tumors and Sensitize a Range of Cancer Cell Types to Chemotherapy , 2012, Science Translational Medicine.

[12]  M. Seckl,et al.  HIF-2α expression is suppressed in SCLC cells, which survive in moderate and severe hypoxia when HIF-1α is repressed. , 2012, The American journal of pathology.

[13]  Brian Keith,et al.  HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression , 2011, Nature Reviews Cancer.

[14]  R. Memmott,et al.  Metformin Prevents Tobacco Carcinogen–Induced Lung Tumorigenesis , 2010, Cancer Prevention Research.

[15]  W. Hsu,et al.  Prognostic significance of hypoxia-inducible factor-1α, TWIST1 and Snail expression in resectable non-small cell lung cancer , 2009, Thorax.

[16]  J. Buhmann,et al.  Protein Identification False Discovery Rates for Very Large Proteomics Data Sets Generated by Tandem Mass Spectrometry* , 2009, Molecular & Cellular Proteomics.

[17]  A. Jemal,et al.  Cancer Statistics, 2009 , 2009, CA: a cancer journal for clinicians.

[18]  E. Åvall-Lundqvist,et al.  Ovarian carcinoma cells with low levels of β-F1-ATPase are sensitive to combined platinum and 2-deoxy-d-glucose treatment , 2009, Molecular Cancer Therapeutics.

[19]  William Stafford Noble,et al.  Improvements to the percolator algorithm for Peptide identification from shotgun proteomics data sets. , 2009, Journal of proteome research.

[20]  Lukas M Orre,et al.  Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer. , 2009, Lung cancer.

[21]  Anthony Mancuso,et al.  Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction , 2008, Proceedings of the National Academy of Sciences.

[22]  H. Kalbacher,et al.  Cathepsin D: a cellular roadmap. , 2008, Biochemical and biophysical research communications.

[23]  N. Denko,et al.  Hypoxia, HIF1 and glucose metabolism in the solid tumour , 2008, Nature Reviews Cancer.

[24]  B. Persson,et al.  Quantitative membrane proteomics applying narrow range peptide isoelectric focusing for studies of small cell lung cancer resistance mechanisms , 2008, Proteomics.

[25]  V. Shoshan-Barmatz,et al.  Uncovering the role of VDAC in the regulation of cell life and death , 2008, Journal of bioenergetics and biomembranes.

[26]  William Stafford Noble,et al.  Semi-supervised learning for peptide identification from shotgun proteomics datasets , 2007, Nature Methods.

[27]  F. López-Ríos,et al.  Loss of the mitochondrial bioenergetic capacity underlies the glucose avidity of carcinomas. , 2007, Cancer research.

[28]  J. Crowley,et al.  The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[29]  V. Vetvicka,et al.  Procathepsin D expression correlates with invasive and metastatic phenotype of MDA-MB-231 derived cell lines. , 2007, International journal of biological macromolecules.

[30]  M. Dewhirst,et al.  Expression of HIF-1α, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer , 2005 .

[31]  C. Jun,et al.  Performance of some variable selection methods when multicollinearity is present , 2005 .

[32]  K. Greulich,et al.  Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. , 2004, Genomics.

[33]  Erik Johansson,et al.  Using chemometrics for navigating in the large data sets of genomics, proteomics, and metabonomics (gpm) , 2004, Analytical and bioanalytical chemistry.

[34]  David E. Misek,et al.  The bioenergetic signature of lung adenocarcinomas is a molecular marker of cancer diagnosis and prognosis. , 2004, Carcinogenesis.

[35]  V. Shoshan-Barmatz,et al.  In self-defence: hexokinase promotes voltage-dependent anion channel closure and prevents mitochondria-mediated apoptotic cell death. , 2004, The Biochemical journal.

[36]  G. Semenza,et al.  Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. , 2003, Cancer research.

[37]  John C Reed,et al.  The bioenergetic signature of cancer: a marker of tumor progression. , 2002, Cancer research.

[38]  A. Harris,et al.  Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival , 2001, British Journal of Cancer.

[39]  Alfonso Valencia,et al.  A hierarchical unsupervised growing neural network for clustering gene expression patterns , 2001, Bioinform..

[40]  Bonnie F. Sloane,et al.  Unraveling the role of proteases in cancer. , 2000, Clinica chimica acta; international journal of clinical chemistry.

[41]  G. Semenza,et al.  Hypoxia Response Elements in the Aldolase A, Enolase 1, and Lactate Dehydrogenase A Gene Promoters Contain Essential Binding Sites for Hypoxia-inducible Factor 1* , 1996, The Journal of Biological Chemistry.

[42]  M. Schwartz Tissue cathepsins as tumor markers. , 1995, Clinica chimica acta; international journal of clinical chemistry.

[43]  H. Rochefort,et al.  Regulation of cathepsin-D and pS2 gene expression by growth factors in MCF7 human breast cancer cells. , 1989, Molecular endocrinology.

[44]  V. Shoshan-Barmatz,et al.  VDAC, a multi-functional mitochondrial protein as a pharmacological target. , 2012, Mitochondrion.

[45]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.